These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16937127)

  • 21. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Hildebrandt P; Hess G; Parving HH; Pedersen O
    Diabetologia; 2005 Jan; 48(1):156-63. PubMed ID: 15619076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
    Huelsmann M; Neuhold S; Resl M; Strunk G; Brath H; Francesconi C; Adlbrecht C; Prager R; Luger A; Pacher R; Clodi M
    J Am Coll Cardiol; 2013 Oct; 62(15):1365-72. PubMed ID: 23810874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.
    Kim JY; Lee EY; Jee JH; Lee BW; Chung JH; Jeun ES; Min YK; Lee MS; Kim KW; Lee MK
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S238-42. PubMed ID: 17490778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
    Hamano K; Nakadaira I; Suzuki J; Gonai M
    Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.
    Bruno G; Landi A; Barutta F; Ghezzo G; Baldin C; Spadafora L; Schimmenti A; Prinzis T; Cavallo Perin P; Gruden G
    Diabetes Care; 2013 Sep; 36(9):2677-82. PubMed ID: 23564918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma N-terminal pro-brain natriuretic peptide in Type 1 diabetic patients with and without diabetic nephropathy.
    Siebenhofer A; Ng LL; Plank J; Berghold A; Hödl R; Pieber TR
    Diabet Med; 2003 Jul; 20(7):535-9. PubMed ID: 12823233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.
    Reinhard H; Wiinberg N; Hansen PR; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2011 Aug; 10():71. PubMed ID: 21812947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes.
    Vergès B; Zeller M; Beer JC; Cottin Y;
    Diabetes Metab; 2008 Feb; 34 Suppl 1():S10-5. PubMed ID: 18358421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
    PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.
    Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M
    Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus.
    Neuhold S; Resl M; Huelsmann M; Strunk G; Adlbrecht C; Rath C; Prager R; Luger A; Clodi M; Pacher R
    Eur J Clin Invest; 2011 Dec; 41(12):1292-8. PubMed ID: 21615391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NGAL and NT-proBNP levels in diabetic patients with macroproteinuria.
    Taskapan H; Taskapan MC; Orman I; Ulutas O; Yigit A; Ozyalin F; Yologlu S
    Ren Fail; 2013 Oct; 35(9):1273-7. PubMed ID: 23964619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications.
    Beer S; Golay S; Bardy D; Feihl F; Gaillard RC; Bachmann C; Waeber B; Ruiz J
    Diabetes Metab; 2005 Dec; 31(6):567-73. PubMed ID: 16357805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.